US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CN101579335B
(zh)
*
|
1997-06-27 |
2016-08-03 |
阿布拉科斯生物科学有限公司 |
药剂的制剂及其制备和应用方法
|
CA2294981C
(en)
*
|
1997-06-27 |
2012-04-03 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
SI1052974T1
(sl)
*
|
1998-02-05 |
2009-10-31 |
Novartis Ag |
Farmacevtska formulacija, ki vsebuje epotilon
|
US6979456B1
(en)
*
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
DE69931617T2
(de)
*
|
1998-04-01 |
2007-05-24 |
Jagotec Ag |
Taxan-mikroemulsionen
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
DE19843968A1
(de)
*
|
1998-09-24 |
2000-04-13 |
Hans Dietl |
Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung
|
US6436430B1
(en)
*
|
1998-12-11 |
2002-08-20 |
Pharmasolutions, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
DE19900054A1
(de)
*
|
1999-01-04 |
2000-07-06 |
Hans Dietl |
Taxane enthaltende stabile und sterile Emulsion und Verfahren zu ihrer Herstellung
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
WO2000074653A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Skyepharma, Inc. |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
TW422706B
(en)
|
1999-07-01 |
2001-02-21 |
Wang Iz Rung |
An oil-in-water emulsion type of paclitaxel
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US7732404B2
(en)
*
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
PL350075A1
(en)
*
|
2000-02-02 |
2002-11-04 |
Univ Florida State Res Found |
Taxane formulations having improved solubility
|
US6452024B1
(en)
|
2000-02-22 |
2002-09-17 |
Chaichem Pharmaceuticals International |
Process for extraction and purification of paclitaxel from natural sources
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
WO2002009695A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Atossa Healthcare, Inc. |
Bimodal emulsions of taxanes and butyrate polyalcohol esters
|
CA2449856C
(en)
|
2001-06-15 |
2009-03-10 |
Cornerstone Pharmaceuticals |
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
|
US20040241094A1
(en)
*
|
2001-09-13 |
2004-12-02 |
Hesson Chung |
Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
KR100573289B1
(ko)
*
|
2002-07-20 |
2006-04-24 |
대화제약 주식회사 |
방광내 투여를 통한 방광암치료용 파클리탁셀 조성물 및그의 제조 방법
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
TR200502189T1
(tr)
|
2002-12-09 |
2007-01-22 |
American Bioscience, Inc. |
Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
|
US6759539B1
(en)
|
2003-02-27 |
2004-07-06 |
Chaichem Pharmaceuticals International |
Process for isolation and purification of paclitaxel from natural sources
|
EP1670434A4
(de)
*
|
2003-10-02 |
2010-06-23 |
Sembiosys Genetics Inc |
Verfahren zur herstellung von ölkörpern mit wirkstoffen
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US20050129719A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Yu-Fang Hu |
Concentrated emulsion formulation for silatecan
|
WO2005065677A1
(ja)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
パクリタキセルまたはドセタキセルを溶解または分散させるための脂肪乳剤
|
WO2005065676A1
(ja)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
パクリタキセルまたはドセタキセルを含む脂肪乳剤
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
CN100462076C
(zh)
*
|
2005-01-20 |
2009-02-18 |
江苏正大天晴药业股份有限公司 |
供静脉用长春花生物碱的稳定水包油乳剂及其制备方法
|
CN100333722C
(zh)
*
|
2005-03-11 |
2007-08-29 |
江苏正大天晴药业股份有限公司 |
静脉用棓丙酯的稳定水包油乳剂及其制备方法
|
DE602006017979D1
(de)
*
|
2005-03-14 |
2010-12-16 |
Otsuka Pharma Co Ltd |
Kit enthaltend einen wirkstoff und eine fettemulsion
|
US20070032438A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Tty Biopharm Company Limited |
Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
WO2008058366A1
(en)
*
|
2006-09-28 |
2008-05-22 |
Université de Montréal |
Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof
|
EP2025333A1
(de)
*
|
2007-08-14 |
2009-02-18 |
Pharmatex Italia Srl |
Injizierbare pharmazeutische Taxoidformulierungen
|
US20090087460A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Hamamatsu Photonics K.K. |
Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these
|
US20090098168A1
(en)
*
|
2007-10-08 |
2009-04-16 |
The Regents Of The University Of California |
Multiple-layer microbubble liposphere drug delivery vehicle and system
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
CA2718416C
(en)
*
|
2008-03-13 |
2018-01-02 |
Mallinckrodt Inc. |
Multi-function, foot-activated controller for imaging system
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
CN102048725B
(zh)
*
|
2009-10-29 |
2014-07-16 |
中国医学科学院药物研究所 |
紫杉醇胆固醇复合物
|
CN102048688B
(zh)
*
|
2009-10-29 |
2014-03-05 |
中国医学科学院药物研究所 |
以胆固醇复合物为中间载体的紫杉醇亚微乳
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
EA027666B1
(ru)
*
|
2010-05-03 |
2017-08-31 |
ТЕИКОКУ ФАРМА ЮСЭй, ИНК. |
Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
|
JP2012051823A
(ja)
*
|
2010-08-31 |
2012-03-15 |
Fujifilm Corp |
難容性薬物含有水中油型乳化組成物及びその製造方法
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
KR20150000405A
(ko)
*
|
2013-06-24 |
2015-01-02 |
한국콜마주식회사 |
난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
EP3193830B1
(de)
|
2014-09-19 |
2023-11-01 |
Heron Therapeutics, Inc. |
Aprepitantemulsion
|
US9974742B2
(en)
|
2016-02-01 |
2018-05-22 |
Heron Therapeutics, Inc. |
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|
CN111920782A
(zh)
*
|
2019-05-13 |
2020-11-13 |
中国医学科学院药物研究所 |
复合脂质纳米囊组合物及其制备方法和应用
|